Alinity I system
Device
Abbott Laboratories
Total Payments
$101,580
Transactions
2
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $101,580 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $101,580 | 2 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Troponin I Testing for the Diagnosis of Myocardial Injury after Noncardiac Surgery (MINS) in a Cancer Patient Population | Abbott Laboratories | $101,580 | 0 |
Top Doctors Receiving Payments for Alinity I system
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | New York, NY | $101,580 | 2 |
Ad
Manufacturing Companies
- Abbott Laboratories $101,580
Product Information
- Type Device
- Total Payments $101,580
- Total Doctors 0
- Transactions 2
About Alinity I system
Alinity I system is a device associated with $101,580 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2019 to 2019. In 2019, $101,580 was paid across 2 transactions to 0 doctors.
The most common payment nature for Alinity I system is "Unspecified" ($101,580, 100.0% of total).
Alinity I system is associated with 1 research study, including "Troponin I Testing for the Diagnosis of Myocardial Injury after Noncardiac Surgery (MINS) in a Cancer Patient Population" ($101,580).